Sermorelin vs mk-677: how the two actually compare

Last updated 2026-07-24

what is the real difference between sermorelin and mk-677?

Sermorelin is a synthetic version of growth hormone-releasing hormone (GHRH), the natural signal your hypothalamus sends to your pituitary gland to make it release growth hormone. MK-677 (ibutamoren) works on a different receptor entirely: it mimics ghrelin, the "hunger hormone," and stimulates GH release through the ghrelin receptor pathway rather than the GHRH pathway. The practical difference shows up in how you take them and what legal status they carry. Sermorelin is injected subcutaneously, usually once daily at bedtime, and it has an actual FDA history: it was sold in the US as Geref, approved for diagnosing growth hormone deficiency and for treatment use, before the manufacturer discontinued the branded product for business reasons, not a safety recall ^[1]. MK-677 is a pill, taken orally, and it has never been approved by the FDA for any human use, for any condition ^[2]. That regulatory gap matters more than most comparison articles admit. Sermorelin, even though today's version is compounded rather than sold as an FDA-approved drug, is chemically the same molecule that went through human trials and carried an approved label for years. MK-677 has gone through Phase 2 trials for specific conditions like hip fracture recovery in older adults, but has never cleared the bar for approval anywhere ^[3].

how do sermorelin and mk-677 compare side by side?

Here is the direct comparison most people are looking for before they talk to a prescriber.

which one actually raises growth hormone more effectively?

Both raise GH and IGF-1 levels, but through different mechanisms and with different consistency of data. Sermorelin's GH-releasing effect is well characterized because it was studied as a diagnostic tool: clinicians used it (and still occasionally use GHRH analogs) to test whether a patient's pituitary can respond to GHRH stimulation at all, which requires reliable, reproducible GH release ^[1][4]. MK-677 trials show it reliably raises IGF-1 levels too, sometimes substantially over baseline, in trials lasting weeks to two years ^[5]. But because it acts upstream on ghrelin receptors rather than mimicking the body's own GHRH pulse pattern, it produces a more constant elevation in GH and IGF-1 rather than the natural pulsatile release sermorelin is designed to preserve. Whether that pulsatile pattern versus constant elevation matters clinically for adults without GH deficiency is genuinely unresolved. Nobody has a head-to-head trial comparing sermorelin against MK-677 directly; the two have mostly been studied in separate populations for separate reasons (sermorelin for GH deficiency and diagnosis, MK-677 for frailty, sleep, and appetite in older or wasting populations).

is mk-677 legal or fda-approved?

No. MK-677 has never received FDA approval for any indication. It is often sold labeled "for research purposes only," which is a legal gray zone that lets sellers avoid regulation as a drug or supplement, but that label does not mean it's been vetted for human safety or that buying it for personal use is risk-free ^[2]. Sermorelin sits in a different, though still imperfect, spot. The original branded product Geref went through FDA approval and was on the market for years before being discontinued. Sermorelin used today in the US is typically dispensed by compounding pharmacies under a prescription, which is legal under specific FDA compounding rules but means each batch isn't individually FDA-approved the way Geref once was ^[1]. That's a meaningfully different legal footing than an unapproved research chemical purchased without a prescription.

what does the dosing actually look like for each?

Sermorelin is dosed by injection, typically in the 0.2 mg to 0.3 mg range nightly for adults, timed before bed to work with the body's natural nighttime GH pulse. Some protocols run higher, up to around 0.5 mg, depending on the prescriber's approach and the patient's response. You can see a fuller breakdown on our sermorelin dosage chart, and if you want a starting-point estimate based on your own numbers, the sermorelin dosage calculator walks through it. MK-677 doses used in published trials range widely, commonly 25 mg once daily, though bodybuilding forums often cite higher doses with no clinical basis behind them. Because it's an oral compound with a longer half-life, dosing schedules are simpler on paper (once a day, no injection technique to learn), but the lack of any approved product means there's no standardized, regulator-reviewed dose to point to. Anyone buying MK-677 online is relying entirely on the seller's stated concentration, since there's no FDA oversight confirming what's actually in the vial or capsule.

what are the side effects of sermorelin compared to mk-677?

Sermorelin's most commonly reported side effects are local: redness, itching, or mild swelling at the injection site, along with occasional flushing, headache, or dizziness shortly after dosing ^[4]. Because it works through the body's normal GHRH-pituitary feedback loop, it doesn't override the pituitary's own shutoff signals, which is part of why sermorelin is generally considered to carry a lower risk of overshoot than direct HGH injections. MK-677's side effect profile centers on increased appetite (often significant), fluid retention, joint or muscle aches, and, most notably, changes in glucose metabolism. The 2-year trial in older adults found increased fasting glucose and a higher rate of impaired glucose tolerance in the treatment group ^[5]. Increased appetite might sound appealing to someone trying to gain muscle, but it also means unwanted weight gain is a common complaint. Neither compound has solid long-term (10-plus year) human safety data, so anyone using either should treat that as an open question rather than a settled one. For a longer look at what's known and not known about extended sermorelin use, see sermorelin long-term side effects.

how does sermorelin compare to hgh directly?

This is usually the real question underneath "sermorelin vs MK-677": how does either of these compare to just taking HGH (somatropin) itself? The honest answer is that sermorelin is the gentler, less powerful option, and that's by design. HGH injections put growth hormone directly into your bloodstream, bypassing your pituitary gland entirely. That produces a stronger, more predictable rise in IGF-1, which is why HGH is the standard treatment for diagnosed growth hormone deficiency in both children and adults ^[6]. Sermorelin instead asks your own pituitary to produce and release GH, which means the result depends on how well your pituitary still works. In someone with a healthy, responsive pituitary, sermorelin produces a smaller, more physiologic rise in GH and IGF-1 than direct HGH injection. In someone whose pituitary has significant damage or dysfunction, sermorelin may not work well at all, since there's no gland left to stimulate. Where sermorelin genuinely loses to HGH: speed and magnitude of effect, and reliability in patients with any pituitary impairment. Where sermorelin has an edge: it preserves the body's natural pulsatile GH release pattern and feedback loops, generally carries a lower cost, and (per its history as an FDA-approved diagnostic and treatment agent) has a longer regulatory track record than most compounded peptides on the market today ^[1][4]. If your goal is treating a confirmed GH deficiency, HGH is the evidence-backed first-line treatment; sermorelin is more often positioned as a lower-intensity alternative for people who don't have severe deficiency but want to support their own GH production. For the fuller picture on where sermorelin fits and what it's actually approved and used for, see sermorelin.

why was geref discontinued if sermorelin is still used today?

Geref (sermorelin acetate) was the FDA-approved brand name product, used both as a diagnostic agent to test pituitary GH reserve and, in some formulations, as a treatment for GH deficiency in children ^[1]. The manufacturer discontinued Geref for commercial reasons, not because of a safety recall or an FDA-mandated withdrawal. Discontinuation for business reasons (low sales volume, manufacturing cost, shifting to other products) is common across pharma and doesn't carry the same red flag as a safety-driven withdrawal. After Geref left the market, sermorelin didn't disappear. Compounding pharmacies, working under a prescriber's order, continued (and still continue) to prepare sermorelin acetate for patients, which is legal under FDA compounding rules but means the product is not individually FDA-reviewed the way Geref was. That's an important nuance: sermorelin has real approved-drug history, but what's dispensed today is a compounded version of that history, not the original approved product itself.

can you combine sermorelin and mk-677?

Some online protocols suggest stacking sermorelin with MK-677 on the theory that hitting both the GHRH pathway and the ghrelin pathway at once produces a bigger combined GH response. There's some biological logic to that (they act on different receptors), and a few small studies of GHRH analogs combined with ghrelin-pathway agonists (like the related peptide MK-0677 in earlier research literature, and other GH secretagogues) have shown additive effects on GH pulse amplitude ^[3][5]. But "biologically plausible" isn't the same as "studied and safe." There is no dedicated clinical trial testing sermorelin plus MK-677 together in humans for safety or long-term outcomes. Combining an FDA-history peptide with an unapproved oral compound multiplies your unknowns rather than your confidence. Anyone considering this should do it only under a prescriber's direct supervision with bloodwork monitoring, not based on a forum thread.

who is a better candidate for sermorelin versus mk-677?

If you want a peptide with an actual FDA-approved history, a prescriber-managed dosing protocol, and a side effect profile that's well documented in medical literature, sermorelin is the more defensible choice. It requires nightly injections, which is a real downside for needle-averse people, but the tradeoff is a much clearer regulatory and safety paper trail. If you're drawn to MK-677 because it's a pill and you want to avoid injections, understand what you're trading away: no FDA approval anywhere, less rigorous human safety data, and a documented signal toward worsened glucose control in the longest trial available ^[5]. People with any personal or family history of diabetes or insulin resistance should be especially cautious with MK-677 given that glucose finding. Neither compound is approved or marketed for anti-aging, athletic performance, or bodybuilding use, regardless of how they're advertised online. Sermorelin's approved history was for diagnosing and treating growth hormone deficiency, primarily in children and in adults with confirmed pituitary dysfunction. Using either compound outside that context means you're in largely unstudied territory, and any claims about muscle gain, fat loss, or longevity benefit outrun what the trials actually show.

how do you get sermorelin safely if you decide it's right for you?

Sermorelin should be prescribed after bloodwork confirms a legitimate reason to consider it, typically IGF-1 levels and a clinical evaluation of symptoms consistent with reduced GH production. A qualified prescriber can order stimulation testing if there's a real question about pituitary function, rather than starting therapy on symptoms alone. Because sermorelin used today is compounded rather than sold as an FDA-approved product, sourcing matters. Work with a prescriber who uses a licensed, accredited compounding pharmacy rather than ordering from an unregulated online seller with no prescription requirement, which is exactly the gray-market pattern MK-677 sales fall into. Sermorelin Co connects patients with a provider-reviewed process and works with a licensed fulfilling pharmacy partner so what you're injecting has some chain of accountability behind it, rather than an unlabeled vial from an anonymous supplier. If you want to see what other patients report about the process, sermorelin reviews covers that, and sermorelin peptide near me can help you find a local prescribing option.

Frequently asked questions

Is sermorelin better than MK-677?

Sermorelin has a real FDA history (as Geref) and more established prescribing and safety literature. MK-677 has never been FDA approved for any use. For someone who wants a defensible, prescriber-managed option, sermorelin is generally the stronger choice, though it requires nightly injections rather than a pill.

Does MK-677 raise growth hormone as much as sermorelin?

Both raise GH and IGF-1 levels in trials, through different receptor pathways. There's no direct head-to-head human trial comparing them, so claims that one is definitively "stronger" aren't backed by controlled comparative data.

Is MK-677 safe long term?

The longest published trial ran 2 years in adults over 60 and found increased fat-free mass but also sustained increases in fasting glucose and impaired glucose tolerance versus placebo. There's no long-term safety data beyond that window.

Why is Geref no longer sold?

The manufacturer discontinued the branded product Geref for commercial reasons, not because of an FDA safety recall or withdrawal. Sermorelin acetate is still available today through compounding pharmacies under prescription.

Can you take sermorelin orally like MK-677?

No. Sermorelin is a peptide that breaks down in the digestive tract, so it's given by subcutaneous injection, typically at bedtime. MK-677 is a non-peptide small molecule that survives oral dosing, which is a real practical advantage for people who dislike injections.

Is MK-677 legal to buy?

It's sold in the US under a research-use-only label, which is a legal gray zone rather than an approved drug status. It has never been approved by the FDA for human use, and buying it without a prescription carries no regulatory oversight of purity or dosing accuracy.

What are the main side effects of sermorelin?

Injection site redness, itching or swelling, occasional flushing, headache, or dizziness are the most commonly reported effects. Because it works through the body's own feedback loop, severe overshoot in GH levels is less commonly reported than with direct HGH use.

What are the main side effects of MK-677?

Increased appetite (often significant), fluid retention, joint aches, and elevated fasting blood glucose are the most documented effects, based on trials running up to 2 years in older adults.

Is sermorelin the same as HGH?

No. Sermorelin is a GHRH analog that signals your pituitary to make and release its own growth hormone. HGH (somatropin) is the growth hormone itself, injected directly, which produces a stronger and more direct rise in IGF-1 than sermorelin typically does.

Can sermorelin and MK-677 be combined?

Some protocols pair them because they act on different receptor pathways, but there's no dedicated clinical trial testing the combination for safety in humans. Anyone considering it should only do so under direct prescriber supervision with lab monitoring.

Which is cheaper, sermorelin or MK-677?

MK-677 is often cheaper up front since it's sold as an unregulated oral compound without a prescription. Sermorelin typically costs more because it involves prescriber oversight and compounding pharmacy dispensing, but that cost buys accountability and quality control that unregulated MK-677 sources don't offer.

Does sermorelin help with weight loss like MK-677's appetite effects?

Sermorelin doesn't stimulate appetite the way MK-677 does; MK-677 acts on ghrelin receptors, which drive hunger. Neither compound is FDA approved for weight loss, and any body composition changes reported in trials are modest and secondary to their studied purposes.

Sources

1. FDA, Drugs@FDA record for Geref (sermorelin acetate), NDA 019826: Geref was an FDA-approved sermorelin product later discontinued for commercial reasons, not a safety withdrawal
2. FDA, DEA and FDA public notice on unapproved research chemicals sold online: MK-677 has never been approved by the FDA for any human use
3. Murphy MG et al., "MK-677, an orally active growth hormone secretagogue," PubMed PMID 9435416: MK-677 has undergone Phase 2 human trials for conditions like hip fracture recovery but has not achieved approval
4. MedlinePlus, Sermorelin injection drug information: Sermorelin's typical side effects, half-life, and use as a GH stimulation/diagnostic agent
5. Nass R et al., "Effects of an oral ghrelin mimetic on body composition and clinical outcomes," PubMed PMID 18316753: MK-677 (ibutamoren) half-life and mechanism as a ghrelin receptor agonist, and 2-year trial in older adults
6. Endocrine Society, 2019 Clinical Practice Guideline on Growth Hormone Deficiency in Adults, Journal of Clinical Endocrinology and Metabolism: HGH (somatropin) is the standard direct treatment for diagnosed growth hormone deficiency
7. ClinicalTrials.gov, study record for ibutamoren (MK-677) in adults, NCT00071617: MK-677 has been studied in registered clinical trials for effects on GH/IGF-1 and body composition without achieving FDA approval